Investigation Commenced on Behalf of Great Basin Scientific, Inc. Shareholders -- GBSN

Roy Jacobs & Associates announces that it has commenced an investigation as to whether the Board of Directors of Great Basin Scientific, Inc. (“GBSN” or “the Company”) has breached its fiduciary duties and, if so, what legal action can be taken to protect shareholder interests and the interests of the Company.

The investigation centers on the Company’s sale on February 25, 2015 of 2,724,000 units (“Units”) in a public offering, which (upon conversion into preferred stock and warrants) resulted in an obligation to issues hundreds of millions of new shares, reducing the stock to a price of about 6 cents a share from its 2015 high of $6.10. This catastrophic development, besides eviscerating most of the shareholder value in the Company, threatens GBSN’s ability to raise needed cash and maintain its stock listing.

The GBSN directors now seek, via proxy solicitation, to effect a reverse split of the stock, without offering a complete explanation as to how and why GBSN has found itself in this predicament.

If you hold GBSN shares and wish to discuss potentially joining in an action to protect your rights and those of GBSN, or have any questions concerning this notice or your rights with respect to this matter, please contact Roy Jacobs. Mr. Jacobs will personally speak with you at no cost or obligation.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151118006476/en/